Together with our reputable Indian and international collaborators, Hexaphoenix Pharma offers you a broad portfolio of Prescription medicines, OTC and General Pharmacy products in various indications and in different development stages up to finished products – ready for market.
We believe in partnerships. We are not looking for “clients” or “customers” but for partners. We believe in long-term relationships that bring value to both businesses.
Hexaphoenix Pharmaceutical product enriches superior recognition, largely due to consistent customer satisfaction. We maintain world-class quality for our products and services across domestic and overseas markets, thus ensuring that every patient has access to the best medicines in the world.
The company plans to expand its footprint in the same therapy with molecules approved from EUGMP and UKMHRA authorities to represent it in all the dosage forms in semi regulated markets such as Latin America, Africa, CIS and South East Asia.
Always welcome partner companies who provide their approved molecules from Regulated Authorities as In-Licensing to make it available for other markets where patent are expiry to collaboration with us.
Our Service for Finished Pharmaceutical Product contains:
Strength: 100mg /200mg
Dosage: Capsules
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 75mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 250mg /500mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 1.25mg /2.5mg/3.75mg/5mg/7.5mg/10mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10mg/20mg/30mg/40mg/60mg
Dosage: Capsules
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD / ACTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 30mg/60mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 40/160mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 500mg/750mg/1000mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10mg/25mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10/25mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: Prochlorperazine | Tablet | 5mg
Prochlorperazine (OTC) | Buccal Tablet | 3mg
Prochlorperazine (Prescription Only) | Buccal Tablet | 3mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 250 mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10 mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10 mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 7.5mg/5ml, 30mg/5ml
Dosage: Syrup
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 5/10/20/25mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 375mg
Dosage: Capsules
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD / ACTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 250mg/5ml
Dosage: Syrup
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 800mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 5mg / 7.5mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 5mg/5ml
Dosage: Syrup
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 30 mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 50/100mg
Dosage: Capsules
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 12.5/25/50/100mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 0.5mg / 0.75mg / 1.0mg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 2mg + 125mg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 2mg + 125mg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 2mg
Dosage: ODT (Lingual) Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 8mg /16mg / 24mg /48mg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 0.5mg / ml
Dosage: Oral Solution
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 500 mg / 1000mg
Dosage: Granules in Sachet
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 1mg/5mg/10mg
Dosage: Film Coated Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 62.5 mcg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 5 IU and 10 IU
Dosage: Injection
Approved Authority: WHO Prequalified and From EUGMP Approved Plant
Dossiers Available: Ready CTD
Bioequivalence (BE/BA) study: Not Required for Injection
Market Availability: Not available for Ghana, Tanzania, Vietnam, Sri Lanka.